The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
  • Is CBD ‘Harmful’ to Our Liver? No.
  • Industry Leaders Leading Turnaround in Marijuana Stocks?

Articles

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

2022-04-27 PSW Editor

Private psychedelics company, Terran Biosciences announces a drug development partnership with Sanofi S.A. for the development and commercialization of two late-stage CNS drugs.

Psychedelic Drug Patenting: Still Only Scratching The Surface

2022-04-25 Jeff Nielson

Dozens of psychedelic drugs to research. Several "generations" of R&D ahead. To say that we're early in the game with psychedelic drug research is an understatement.

TRYP THERAPEUTICS INC. Announces Amendment to Terms of Private Placement and Closing of $3,000,000 Second Tranche

2022-04-25 PSW Editor

Tryp Therapeutics closes the second tranche of its recently announced private placement for gross proceeds of CAD$3 million. Units are priced at CAD$0.15.

Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

2022-04-21 PSW Editor

Cybin announces a new clinical partner as it prepares for its Phase 1/2a clinical trial for CYB003.

Kevin O’Leary Predicts These 3 Psychedelic Companies Will Merge, But Should They?

2022-04-21 James Hallifax

The "Shark Tank" star predicts three of the biggest psychedelic companies will merge into a mega corporation, but our resident Psychedelic Investor wonders: Should they?

Revitalist Reports Fourteen Months of Consecutive Monthly Visit Growth and a 466% Increase Year over Year for March 2022

2022-04-20 PSW Editor

Revitalist Lifestyle and Wellness announces 14th consecutive month of revenues growth and projects further growth across its network of 9 clinics.

Looking For The Perfect Inflation Hedge? Try This Company

2022-04-19 Jeff Nielson

Inflation is rapidly eroding our purchasing power and consuming our wealth. Here is a powerful antidote for investors.

Veterans Push to Persuade Lawmakers to Legalize Therapeutic Use of Psychedelics

2022-04-18

New studies have indicated psilocybin could be useful in the treatment of everything from major depression to alcoholism.

Mydecine Announces Reverse Stock-Split

2022-04-14 PSW Editor

Mydecine Innovations Group announces a share consolidation of 1 post-consolidation share for every 50 pre-consolidation shares.

Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds

2022-04-14 PSW Editor

Delic Holdings announces receiving a Health Canada 56 Research Exemption to conduct research on various psychedelic drugs.

Red Light Holland Sponsors First Of Its Kind Group Microdosing Concert In The Netherlands

2022-04-13 PSW Editor

Red Light Holland to sponsor a "microdosing concert" in The Netherlands, given by mezza-soprano Helena van Heel.

Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

2022-04-13 PSW Editor

Awakn Life Sciences reports that it now has three clinics in operation, including its new flagship clinic in London.

Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT

2022-04-13

In many studies, DMT has shown to be a promising and effective psychedelic for the treatment of mental health issues.

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

2022-04-12 PSW Editor

Numinus Wellness is acquiring Novamind Inc in an all-share deal valued at CAD$26.2 million, creating an industry leader in research AND treatment.

Magic mushrooms can lead to long-term improvements in depression, study finds

2022-04-12 Maria Jimenez Moya

Magic mushroom's drug psilocybin can lead to long-term improvements in depression symptom severity, a small study has found.

  • Previous
  • 1
  • ...
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • ...
  • 302
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

2020-08-31
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

What Does Field Trip Psychedelics Offer Investors?

Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll

Articles
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2023, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor